DECISION GUIDE · UPDATED 2026-06-07
Best Peptide for Muscle RecoveryBPC-157 · TB-500 · GHK-Cu · Stack protocols
TL;DR. For a specific tendon, ligament, or local soft-tissue injury, BPC-157 is the standard first-line research peptide. For systemic recovery or multi-site work, TB-500 takes the lead. Most experienced research protocols use the two together. GHK-Cu adds collagen synthesis and is the topical/skin-level companion.
Top Pick · Local Tissue Repair
BPC-157
The most-researched peptide for tendon, ligament, and gut tissue repair. Standard research dose: 500 micrograms per day subcutaneously near the injury site. Cycle 4 to 8 weeks on, 2 to 4 weeks off. Standard reconstitution: 5 mg vial + 2 mL BAC water = 2500 mcg/mL = 20 IU draw on a 100-unit insulin syringe.
Open BPC-157 calculator →
Runners-up
TB-500
Systemic Remodeling
Thymosin Beta-4 fragment. Promotes systemic actin sequestration, angiogenesis, and immune cell migration. Standard research dose: 2 to 5 mg subcutaneously twice weekly. Often paired with BPC-157.
TB-500 calculator →
GHK-Cu
Collagen + Skin
Copper peptide driving collagen synthesis and metalloproteinase regulation. Subcutaneous 2 mg per day or topical preparations. Strong for skin remodeling, scar healing, and post-surgical recovery.
GHK-Cu calculator →
KPV
Anti-Inflammatory
Alpha-MSH tripeptide suppressing NF-kB and TNF-alpha signaling. Used in gut barrier and chronic inflammation protocols. Standard research dose: 500 micrograms per day SC.
KPV calculator →
Thymosin Alpha-1
Immune Modulation
T-cell function modulator. Researched for post-infectious recovery, chronic inflammation, and immune-compromised states. Often combined with BPC-157 in gut and immune protocols.
Thymosin Alpha-1 calculator →
Decision tree
- Specific tendon, ligament, or joint injury: BPC-157 SC near the injury site, 250-500 micrograms per day.
- Multiple injury sites or systemic recovery need: TB-500 2-5 mg SC twice weekly.
- Post-surgical or scar remodeling: GHK-Cu SC 2 mg per day or topical preparation, often paired with BPC-157.
- Gut healing focus (post-NSAID, IBS, IBD research): BPC-157 + KPV stack. Both peptides SC daily near the abdomen.
- Maximum effect across all tissue compartments: BPC-157 + TB-500 + GHK-Cu, the "Wolverine" stack. Separate sites and syringes.
- Chronic inflammation with immune component: BPC-157 + Thymosin Alpha-1. Address gut barrier and immune tone simultaneously.
Top stack protocols
BPC-157 + TB-500
The classic systemic recovery stack. Combine local repair and systemic remodeling.
Full BPC-157 + TB-500 protocol →
BPC-157 + GHK-Cu
Tissue repair plus collagen synthesis. Use for tendon, skin, and post-surgical recovery.
Full BPC-157 + GHK-Cu protocol →
BPC-157 + KPV
Gut barrier repair plus alpha-MSH anti-inflammatory action.
Full BPC-157 + KPV protocol →
TB-500 + GHK-Cu
Angiogenesis and collagen synthesis combined. Used in wound healing research.
Full TB-500 + GHK-Cu protocol →
Side-by-side at a glance
| Peptide | Standard dose | Cadence | Mechanism focus |
|---|---|---|---|
| BPC-157 | 500 mcg | Daily SC | Local tissue repair |
| TB-500 | 2-5 mg | 2x weekly SC | Systemic remodeling, angiogenesis |
| GHK-Cu | 2 mg | Daily SC or topical | Collagen, copper-dependent skin repair |
| KPV | 500 mcg | Daily SC | Anti-inflammatory, gut barrier |
| Thymosin Alpha-1 | 1.6 mg | 2-3x weekly SC | T-cell function, immune tone |
Open the calculators
Research informational use only. BPC-157, TB-500, GHK-Cu, KPV, and Thymosin Alpha-1 are not FDA-approved finished drug products. Always verify a current Certificate of Analysis from the supplying source.
Frequently asked
Which peptide is best for tendon and ligament healing?
BPC-157 is the most-researched peptide for tendon and ligament repair. Animal studies show accelerated healing of Achilles transections, ligament tears, and tendon-to-bone interface injuries via growth factor receptor modulation and NO system effects. Standard research dose: 250 to 500 micrograms subcutaneously per day for 4 to 8 weeks.
BPC-157 vs TB-500, which one is better?
BPC-157 acts locally at sites of injury through growth factor receptor modulation; TB-500 is a systemic regulator promoting angiogenesis and immune cell migration. For a specific tendon or ligament injury, BPC-157 is the typical first choice. For systemic recovery, multiple-site injuries, or muscle remodeling, TB-500 has the edge. Most research protocols use them together.
Can BPC-157 and TB-500 be used together?
Yes. The BPC-157 + TB-500 stack is the most-studied combination protocol in regenerative peptide research. Typical schedule: BPC-157 250-500 micrograms SC daily near the injury site, TB-500 2 to 5 mg SC twice weekly systemically. Run 4 to 8 weeks then washout.
How long should I use BPC-157?
Most research protocols run 4 to 8 weeks at therapeutic doses (250 to 500 micrograms per day), followed by a 2 to 4 week washout. Some chronic-pain or post-surgical protocols extend longer with the same washout pattern between courses.
What is the standard BPC-157 dose for injury recovery?
Standard ASCEND research reference: 500 micrograms per day subcutaneously, typically reconstituted from a 5 mg vial with 2 mL of bacteriostatic water (2,500 mcg/mL concentration, 0.2 mL or 20 IU draw on a 100-unit insulin syringe). Adjust based on the specific research protocol.
Are recovery peptides legal?
BPC-157 and TB-500 are research peptides in the United States. They are not FDA-approved as finished drug products. They are sold for research use only by peptide-supply companies; clinical compounding under physician prescription is in regulatory flux. Always verify a current Certificate of Analysis from the supplier.
For research informational use only. Not medical advice.